Johnson & Johnson to Name Vice Chairman Gorsky as CEO, WSJ Says

Johnson & Johnson (JNJ), the world’s second-biggest seller of health-care products, will name Alex Gorsky its next chief executive, the Wall Street Journal reported citing a person familiar with the matter.

Gorsky, 51, head of the medical-devices unit, will succeed William C. Weldon, 63, in April as the New Brunswick, New Jersey-based company’s ninth leader in its 126-year-history, the newspaper said.

To contact the editor responsible for this story: Andrew Pollack at apollack1@bloomberg.net

Press spacebar to pause and continue. Press esc to stop.

Bloomberg reserves the right to remove comments but is under no obligation to do so, or to explain individual moderation decisions.

Please enable JavaScript to view the comments powered by Disqus.